申请人:NantBioScience, Inc.
公开号:US20180086752A1
公开(公告)日:2018-03-29
Compounds and compositions are presented that inhibit K-ras, and especially mutant K-ras. Certain compounds preferentially or even selectively inhibit specific forms of mutant K-Ras, and particularly the G12D mutant form.
提供了抑制K-ras,尤其是突变K-ras的化合物和组合物。某些化合物优先或甚至选择性地抑制特定形式的突变K-Ras,特别是G12D突变形式。